WY-50295 [CAS 123016-21-7]

WY-50295 is an orally active and selective 5-lipoxygenase inhibitor. WY-5029 inhibits LTB4 formation in rat whole blood leukocytes (IC50: 40 μM and oral ED50: 18 mg/kg) . WY-50295 can be used in the study of asthma and other leukotriene-dependent diseases[1].

[123016-21-7]

C23H19NO3

357.4

OC([C@@H](C)C1=CC=C2C(C=CC(OCC3=NC(C=CC=C4)=C4C=C3)=C2)=C1)=O

Lipoxygenase

Room temperature